Another strong week for $LGND so far. I see the risk of a doji week now less likely given last nights of a partial halt in the trial of the Vertex nuc. Remember...what's bad for nucs may be bad for HepC pts... but good for INFs and thus Promacta and the $LGND revenue line.
Rather surprised $LGND didn't get a 3% up day on this news...clearly we face a tad resistance at $50 the mark. Why... why do seller pile up at round numbers? Outside reversal day had us a wee bit nervous till today. Now it seems our task next week is to break and close over $50.
More good news for LGND today (orphan designation/CHMP opinion). LGND has not put out a piece of bad news in years (since the reverse split?) Then with the nucs having trouble as well, seems like everything is going their way.